Brugada syndrome; diagnosis, risk stratification and management: a mini-review


Jefrin Daniel E*, Subash Chandran.M.P, Sree Lekshmi.R.S and Prasobh G R

Brugada syndrome is an unprecedented inherited arrhythmia syndrome which may lead to an increased risk of unexpected cardiac loss of life, in spite of a structurally regular heart. Symptoms include palpitations, syncope, nocturnal agonal respiration, ventricular fibrillation. Diagnosis is primarily based totally on a specific electrocardiogram pattern, determined both spontaneously and in the course of a sodium channel blocker test. Some pathogenic genes are identified as the causative agents of the disease. Among those SCN5A is the most prevalent one among affected sufferers Key stratification stays a venture, in spite of latest insights from big population cohorts. Implantable cardiac defibrillators are the primary remedy in management of Brugada syndrome which is related to excessive complications in the population. This review explains the genetic basis, diagnosis, risk stratification, management and steps for enhancing good health care team outcomes.

Share this article

Awards Nomination

Select your language of interest to view the total content in your interested language

Indexed In
  • Index Copernicus
  • Google Scholar
  • Academic Keys
  • CiteFactor
  • Cosmos IF
  • Electronic Journals Library
  • Directory of Abstract Indexing for Journals
  • OCLC- WorldCat
  • Scientific Journal Impact Factor (SJIF)
  • ZB MED
  • Eurasian Scientific Journal Index
  • German cancer Research Center
  • International Institute of Organized Research
  • University of Vechta Library
  • Prerna Society of Technical Education and Research
  • Database for Statistics on Higher Education (DBH)
  • The Hamburg State University Library
  • University Library of Humboldt-Universität zu Berlin, Germany